C+SCAV和SEAM两种预处理方案自体造血干细胞移植治疗非霍奇金淋巴瘤的疗效与安全性比较

OBJECTIVE: This study aimed to compare the efficacy and safety of cladribine, smustine, etoposide, cyclophosphamide, and cytarabine（C+SCAV）and smustine, etoposide, cytarabine, and melphalan（SEAM）conditioning regimens in autologous stem cell transplantation（auto-HSCT）for non-Hodgkin's lymphoma（N...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2022
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593007/
https://www.ncbi.nlm.nih.gov/pubmed/36709152
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.08.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593007/
https://www.ncbi.nlm.nih.gov/pubmed/36709152
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.08.009

Ejemplares similares